September 12, 2017 – Pritzker Levine LLP partner Elizabeth C. Pritzker has been appointed as the Chair of the Plaintiffs’ Steering Committee in the pending multidistrict class action litigation alleging that Mylan, the maker of the EpiPen, engaged in monopolization and other violations of state … [Read more...]
Firm News
Pritzker Levine LLP Files Class Action Lawsuit Against German Car Manufacturers for Anticompetitive Conduct
August 29, 2017 – Pritzker Levine LLP announced today that it has filed a class action complaint against German automobile manufacturers Mercedes-Benz, Volkswagen, Porsche, BMW and Audi, and supplier Bosch. The complaint alleges that the manufacturers and Bosch have engaged in a decades-long cartel … [Read more...]
Three Pritzker Levine LLP Attorneys Named Super Lawyers
July 7, 2017 (Oakland, CA) – Pritzker Levine LLP is proud to announce that three of the firm’s attorneys were selected as 2017 Northern California Super Lawyers and Rising Stars. Pritzker Levine partners Elizabeth C. Pritzker and Jonathan K. Levine and special counsel Bethany L. Caracuzzo have all … [Read more...]
Pritzker Levine LLP Retained to Represent Investor Group in SRA Funds Litigation
May 24, 2017 – Pritzker Levine LLP has been retained to represent the interests of the SRA Funds Investor Group in connection with ongoing litigation brought by the U.S. Securities and Exchange Commission concerning the solicitation of investors for the SRA Funds and the management of those Funds. … [Read more...]
Pritzker Levine LLP Announces Preliminary Approval of $209 Million Class Action Damages Settlement in the NCAA Grant-in-Aid Cap Antitrust Litigation
March 21, 2017 – Pritzker Levine LLP announced today the preliminary approval of the $208,664,445 class action settlement on behalf of the damages class in the NCAA Grant-in-Aid Cap Antitrust Litigation brought on behalf of current and former NCAA Division I college football and basketball … [Read more...]